Effect of Early Treatment with Ivermectin among Patients with Covid-19, New England Journal of Medicine

A new clinical trial, conducted by a partnership between academics and clinicians in Brazil and Canada, found that anti-parasitic drug Ivermectin does not reduce the risk of hospitalisation for patients with COVID-19. The peer-reviewed study also showed ivermectin treatment did not help with various other health measures related to the virus such as viral clearance after a week, speed of recovery or risk of death.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news